Glaucoma patients who take medication for the condition appear to have a reduced likelihood of death, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives ...

In matched cohorts of more than 41,000 patients each, use of tirzepatide was linked to a significantly reduced risk of primary open-angle glaucoma compared with selective GLP-1 receptor agonists (risk ...

Philadelphia, December 28, 2007 – In the United States, the management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated ...

Glaucoma, caused by high pressure within the eye, affects some 2.5 million Americans and is the nation's second leading cause of blindness. Optometrists screen for it during routine eye exams, often ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma-related ocular surface disease is a significant and often underdiagnosed ocular comorbidity that can ...

Expert Rev Ophthalmol. 2010;5(3):405-412. Benzalkonium chloride is the most common preservative in antiglaucoma preparations and its toxic effects depend on the dose and duration of exposure. Chronic ...

Prices of branded glaucoma medications increased in the U.S. over the past 7 years, according to a study published in the Journal of Glaucoma. “Reducing IOP is the only proven method to treat glaucoma ...

Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...

Glaucoma, the silent thief of sight, damages the optic nerve without early symptoms, leading to irreversible vision loss.

A leading Army hospital in Delhi conducted India's inaugural 3D flex aqueous angiography with iStent, combining advanced ...